ACOT11 and neoplasm: In vivo studies confirmed that salidroside and miR-1343-3p agomir reduced tumor size, volume, and weight, upregulated miR-1343-3p expression, downregulated ACOT11 at the gene and protein levels, increased fatty acyl-CoA concentration, and decreased acetyl-CoA, FFA, and ATP concentrations.